![]() | Up a level |
Cain, Lauren E., Saag, Michael S., Petersen, Maya, May, Margaret T., Ingle, Suzanne M., Logan, Roger, Robins, James M., Abgrall, Sophie, Shepherd, Bryan E., Deeks, Steven G., Gill, M. John, Touloumi, Giota, Vourli, Georgia, Dabis, Francois, Vandenhende, Marie-Anne, Reiss, Peter, van Sighem, Ard, Samji, Hasina ORCID: 0000-0002-4555-7609, Hogg, Robert S., Rybniker, Jan, Sabin, Caroline A., Jose, Sophie, del Amo, Julia, Moreno, Santiago
ORCID: 0000-0002-2843-1094, Rodriguez, Benigno, Cozzi-Lepri, Alessandro, Boswell, Stephen L., Stephan, Christoph, Perez-Hoyos, Santiago
ORCID: 0000-0001-9797-4917, Jarrin, Inma, Guest, Jodie L., Monforte, Antonella D'Arminio, Antinori, Andrea
ORCID: 0000-0003-2121-4684, Moore, Richard, Campbell, Colin N. J., Casabona, Jordi, Meyer, Laurence, Seng, Remonie, Phillips, Andrew N., Bucher, Heiner C., Egger, Matthias
ORCID: 0000-0001-7462-5132, Mugavero, Michael J., Haubrich, Richard, Geng, Elvin H., Olson, Ashley, Eron, Joseph J., Napravnik, Sonia, Kitahata, Mari M., Van Rompaey, Stephen E., Teira, Ramon, Justice, Amy C., Tate, Janet P., Costagliola, Dominique
ORCID: 0000-0003-0765-0869, Sterne, Jonathan A. C. and Hernan, Miguel A.
(2016).
Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy.
Int. J. Epidemiol., 45 (6).
S. 2038 - 2050.
OXFORD:
OXFORD UNIV PRESS.
ISSN 1464-3685
Stirrup, Oliver, Sterne, Jonathan, Dunn, David T., Grabmeier-Pfistershammer, Katharina, Papastamopoulos, Vasileios, Vandenhende, Marie-Anne, Wit, Ferdinand, Porter, Kholoud, Gunsenheimer-Bartmeyer, Barbara, Jarrin, Inma, Garcia, Federico ORCID: 0000-0001-7611-781X, Faetkenheuer, Gerd, Obel, Niels, Schultze, Anna, Antinori, Andrea, Ceccherini-Silberstein, Francesca, Mussini, Cristina, Chene, Genevieve, Neesgaard, Bastian, Castagna, Antonella, Kouyos, Roger, De Wit, Stephane, Sonnerbor, Anders, Sabin, Caroline, Merino, Dolores, Barger, Diana and Phillips, Andrew
(2019).
Long-term virological suppression on first-line efavirenz plus tenofovir=emtricitabine/lamivudine for HIV-1.
Aids, 33 (4).
S. 745 - 752.
PHILADELPHIA:
LIPPINCOTT WILLIAMS & WILKINS.
ISSN 1473-5571